A biotech startup based in Uruguay has successfully completed early-stage human trials for a first-in-class drug that targets fat cells to burn more calories, even while the body is at rest. Developed ...

Consider the delicate web of fat in a Wagyu steak. The "marbling" that makes carnivore connoisseurs swoon is a visual ...

Here’s the thing – only about 1% of Americans follow a strictly vegan diet according to a 2023 Gallup poll, […] The post Your ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.

With non-alcoholic fatty liver disease (NAFLD) affecting a significant portion of adults, experts suggest adopting lifestyle ...